comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 17:19:49 - browse：7566

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

entertainment

WSS

Why Sanofi got shellacked over its spinoff

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Future doctors need a strong humanities education

FDA endorses new sterilization method for medical devices

Diversifying clinical trials isn't enough to close racial gaps: study

hotspot

comprehensive

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Prior authorization reform is both possible and imperative

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: XBI biotech index, Akero Therapeutics

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Head of FDA's diagnostics center, who led through Covid, retires

Novavax promises a turnaround & Lilly roils the obesity market

Immunocompromised patients offer clues on chronic Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

knowledge

Cardiologists urge adding sexual orientation, gender identity to health records

Flu vaccine reformulation won't be easy, manufacturers warn

High breast density mammograms need follow

Pumping milk in bathrooms at health conferences is common

FDA has safety concerns on CRISPR

WHO may add ‘noma' to its list of neglected tropical diseases

focus

entertainment

knowledge

leisure time